Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 1, pp. 105949-105949
Open Access | Times Cited: 4850

Showing 1-25 of 4850 citing articles:

The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay, Chek Meng Poh, Laurent Rénia, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 6, pp. 363-374
Open Access | Times Cited: 4293
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
James M. Sanders, Marguerite L. Monogue, Tomasz Z. Jodlowski, et al.
JAMA (2020)
Closed Access | Times Cited: 2398
COVID-19 pathophysiology: A review
Koichi Yuki, Miho Fujiogi, Sophia Koutsogiannaki
Clinical Immunology (2020) Vol. 215, pp. 108427-108427
Open Access | Times Cited: 2137
Coronavirus Disease 2019–COVID-19
Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 4
Open Access | Times Cited: 1786
Potential Effects of Coronaviruses on the Cardiovascular System
Mohammad Madjid, Payam Safavi‐Naeini, Scott D. Solomon, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 7, pp. 831-831
Closed Access | Times Cited: 1717
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, et al.
The Lancet (2020) Vol. 395, Iss. 10241, pp. 1907-1918
Open Access | Times Cited: 1698
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua D. Geleris, Yifei Sun, Jonathan Platt, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 25, pp. 2411-2418
Open Access | Times Cited: 1662
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1654
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
Timothy M. Rawson, Luke Moore, Nina Zhu, et al.
Clinical Infectious Diseases (2020) Vol. 71, Iss. 9, pp. 2459-2468
Open Access | Times Cited: 1544
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Jason Phua, Li Weng, Lowell Ling, et al.
The Lancet Respiratory Medicine (2020) Vol. 8, Iss. 5, pp. 506-517
Open Access | Times Cited: 1491
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, et al.
The Lancet (2020) Vol. 395, Iss. 10238, pp. 1695-1704
Open Access | Times Cited: 1485
The cytokine storm and COVID‐19
Biying Hu, Shaoying Huang, Lianghong Yin
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 250-256
Open Access | Times Cited: 1450
COVID‐19 diagnosis and management: a comprehensive review
Giuseppe Pascarella, Alessandro Strumia, Chiara Piliego, et al.
Journal of Internal Medicine (2020) Vol. 288, Iss. 2, pp. 192-206
Open Access | Times Cited: 1345
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga, Dao Wen Wang, Yaling Han, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 543-558
Open Access | Times Cited: 1303
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R. Mehra, Sapan S. Desai, Frank Ruschitzka, et al.
The Lancet (2020)
Open Access | Times Cited: 1209
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby, Marion Mafham, Louise Linsell, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 21, pp. 2030-2040
Open Access | Times Cited: 1175
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Eli S. Rosenberg, Elizabeth Dufort, Tomoko Udo, et al.
JAMA (2020) Vol. 323, Iss. 24, pp. 2493-2493
Open Access | Times Cited: 1147
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 7, pp. 859-866
Open Access | Times Cited: 1128
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Víctor J. Costela‐Ruiz, Rebeca Illescas‐Montes, José Manuel Puerta-Puerta, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 54, pp. 62-75
Open Access | Times Cited: 1080
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Alexandre Biasi Cavalcanti, Fernando G Zampieri, Régis Goulart Rosa, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 21, pp. 2041-2052
Open Access | Times Cited: 1072
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2020) Vol. 78, Iss. 7, pp. e83-e102
Open Access | Times Cited: 1010
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Melika Lotfi, Michael R. Hamblin, Nima Rezaei
Clinica Chimica Acta (2020) Vol. 508, pp. 254-266
Open Access | Times Cited: 987
Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
Arno R. Bourgonje, Amaal Eman Abdulle, Wim Timens, et al.
The Journal of Pathology (2020) Vol. 251, Iss. 3, pp. 228-248
Open Access | Times Cited: 985
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Mayla Gabriela Silva Borba, Fernando Val, Vanderson de Souza Sampaio, et al.
JAMA Network Open (2020) Vol. 3, Iss. 4, pp. e208857-e208857
Open Access | Times Cited: 951
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
Adeel Zubair, Lindsay McAlpine, Tova Gardin, et al.
JAMA Neurology (2020) Vol. 77, Iss. 8, pp. 1018-1018
Open Access | Times Cited: 879
Page 1 - Next Page

Scroll to top